|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.22 SEK | -3.01% |
|
-6.94% | +4.89% |
Newbury Pharmaceuticals has received orders for international markets covering shipments during 2023 totaling a value of app. 6.2 MSEK. The international sales activities are conducted by the subsidiary in Switzerland.
Newbury focus on the Scandinavian markets, but international sales opportunities contribute to improved sales and profitability.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.89% | 7.37M | |
| -12.65% | 7.93B | |
| +33.84% | 1.3B | |
| -9.90% | 346M | |
| +6.86% | 278M | |
| +9.44% | 222M | |
| -34.86% | 62.09M | |
| +26.51% | 60.97M |
NEWBURY PHARMACEUTICALS AB 
